- Home
- LEXX vs CTRM Comparison
LEXX vs CTRM Comparison
Compare LEXX & CTRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEXX
- CTRM
- Stock Information
- Founded
- LEXX 2004
- CTRM 2016
- Country
- LEXX Canada
- CTRM Cyprus
- Employees
- LEXX N/A
- CTRM N/A
- Industry
- LEXX Biotechnology: Pharmaceutical Preparations
- CTRM Marine Transportation
- Sector
- LEXX Health Care
- CTRM Consumer Discretionary
- Exchange
- LEXX Nasdaq
- CTRM Nasdaq
- Market Cap
- LEXX 23.9M
- CTRM 21.2M
- IPO Year
- LEXX N/A
- CTRM N/A
- Fundamental
- Price
- LEXX $0.83
- CTRM $2.11
- Analyst Decision
- LEXX Strong Buy
- CTRM
- Analyst Count
- LEXX 1
- CTRM 0
- Target Price
- LEXX $4.00
- CTRM N/A
- AVG Volume (30 Days)
- LEXX 1.4M
- CTRM 36.8K
- Earning Date
- LEXX 11-25-2025
- CTRM 11-06-2025
- Dividend Yield
- LEXX N/A
- CTRM N/A
- EPS Growth
- LEXX N/A
- CTRM N/A
- EPS
- LEXX N/A
- CTRM N/A
- Revenue
- LEXX $615,923.00
- CTRM $67,859,415.00
- Revenue This Year
- LEXX $46.98
- CTRM N/A
- Revenue Next Year
- LEXX $17.26
- CTRM N/A
- P/E Ratio
- LEXX N/A
- CTRM N/A
- Revenue Growth
- LEXX 49.85
- CTRM N/A
- 52 Week Low
- LEXX $0.77
- CTRM $1.91
- 52 Week High
- LEXX $3.05
- CTRM $4.19
- Technical
- Relative Strength Index (RSI)
- LEXX 41.83
- CTRM 47.59
- Support Level
- LEXX $0.83
- CTRM $2.06
- Resistance Level
- LEXX $0.92
- CTRM $2.17
- Average True Range (ATR)
- LEXX 0.07
- CTRM 0.06
- MACD
- LEXX -0.02
- CTRM 0.00
- Stochastic Oscillator
- LEXX 12.97
- CTRM 31.25
About LEXX Lexaria Bioscience Corp.
Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH can increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood-brain barrier. The company has four reportable segments: Intellectual Property Licensing which generates maximum revenue, B2B Production, Research and Development, and Corporate. Geographically, it derives revenue from the United States and Canada.
About CTRM Castor Maritime Inc.
Castor Maritime Inc is a provider of seaborne transportation services for dry bulk cargo, including iron ore, coal, grain, steel products, fertilizers, cement, bauxite, sugar, and scrap metal, among others. The firm operates under three reportable segments namely (i) the dry bulk segment (ii) the containership segment and (iii) the asset management segment. It generates maximum revenue from the Dry bulk segment.